Carregant...
Tipus de document
ArticleVersió
Versió publicadaData de publicació
Llicència de publicació
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/202049
2023 GEIS Guidelines for gastrointestinal stromal tumors
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
Gastrointestinal stromal tumor (GIST) is the most common malignant neoplasm of mesenchymal origin. GIST spans a wide clinical spectrum that ranges from tumors with essentially no metastatic potential to malignant and life-threatening spread diseases. Gain-of-function mutations in KIT or PDGFRA receptor tyrosine kinases are the crucial drivers of most GISTs, responsible for tumor initiation and evolution throughout the entire course of the disease. The introduction of tyrosine kinase inhibitors targeting these receptors has substantially improved the outcomes in this formerly chemoresistant cancer. As of today, five agents hold regulatory approval for the treatment of GIST: imatinib, sunitinib, regorafenib, ripretinib, and avapritinib. This, in turn, represents a success for a rare neoplasm. During the past two decades, GIST has become a paradigmatic model in cancer for multidisciplinary work, given the disease-specific particularities regarding tumor biology and tumor evolution. Herein, we review currently available evidence for the management of GIST. This clinical practice guideline has been developed by a multidisciplinary expert panel (oncologist, pathologist, surgeon, molecular biologist, radiologist, and representative of patients' advocacy groups) from the Spanish Group for Sarcoma Research, and it is conceived to provide, from a critical perspective, the standard approach for diagnosis, treatment, and follow-up.
Matèries (anglès)
Citació
Citació
SERRANO, César, MARTÍN BROTO, Javier, ASENCIO PASCUAL, José manuel, LÓPEZ GUERRERO, José antonio, RUBIÓ CASADEVALL, Jordi, BAGUÉ, Silvia, GARCÍA DEL MURO, Xavier, FERNÁNDEZ HERNÁNDEZ, Juan ángel, HERRERO, Luís, LÓPEZ POUSA, Antonio, POVEDA, Andrés, MARTÍNEZ MARÍN, Virginia, GEIS (Grupo Español de Investigación en Sarcomas/Spanish Group for Sarcoma Research). 2023 GEIS Guidelines for gastrointestinal stromal tumors. _Therapeutic Advances in Medical Oncology_. 2023. Vol. 15, núm. 17588359231192388. [consulta: 20 de gener de 2026]. ISSN: 1758-8359. [Disponible a: https://hdl.handle.net/2445/202049]